Related references
Note: Only part of the references are listed.Clinical Use of PET/CT in Peritoneal Carcinomatosis from Colorectal Cancer
Yoshiko Bamba et al.
HEPATO-GASTROENTEROLOGY (2012)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
Toshiaki Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer
Federica Fiocchi et al.
CLINICAL IMAGING (2011)
Low preoperative serum albumin in colon cancer: a risk factor for poor outcome
Cheng-Chou Lai et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
First Alert for Recurrence During Follow-up After Potentially Curative Resection for Colorectal Carcinoma: CA 19-9 Should Be Included in Surveillance Programs
Yutaka J. Kawamura et al.
CLINICAL COLORECTAL CANCER (2010)
Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer
C. S. D. Roxburgh et al.
COLORECTAL DISEASE (2010)
Does Serum Carcinoembryonic Antigen Elevation in Patients With Postoperative Stage II Colorectal Cancer Indicate Recurrence? Comparison With Stage III
Masayasu Hara et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Influence of Inflammation-Based Prognostic Score on Mortality of Patients Undergoing Chemotherapy for Far Advanced or Recurrent Unresectable Colorectal Cancer
Mitsuru Ishizuka et al.
ANNALS OF SURGERY (2009)
Comparison of the Prognostic Value of Inflammation-Based Pathologic and Biochemical Criteria in Patients Undergoing Potentially Curative Resection for Colorectal Cancer
Campbell S. D. Roxburgh et al.
ANNALS OF SURGERY (2009)
Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level
In Ja Park et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Clinical significance of tumor markers and an emerging perspective on colorectal cancer
Keishi Yamashita et al.
CANCER SCIENCE (2009)
Systemic inflammation, nutritional status and survival in patients with cancer
Donald C. McMillan
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer
Ryo Takagawa et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer
I. Sobhani et al.
BRITISH JOURNAL OF CANCER (2008)
Negative Serum Carcinoembryonic Antigen has Insufficient Accuracy for Excluding Recurrence from Patients with Dukes C Colorectal Cancer: Analysis with Likelihood Ratio and Posttest Probability in a Follow-Up Study
Masayasu Hara et al.
DISEASES OF THE COLON & RECTUM (2008)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
Donald C. McMillan
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma
Tadahiro Nozoe et al.
SURGERY TODAY (2008)
What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation
Silke Walleser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer
Mitsuru Ishizuka et al.
ANNALS OF SURGERY (2007)
Current concepts - Computed tomography - An increasing source of radiation exposure
David J. Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Detection of recurrent rectal cancer with CT, MRI and PET/CT
O. Schaefer et al.
EUROPEAN RADIOLOGY (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer
Sara Ramsey et al.
CANCER (2007)
Capecitabine as adjuvant treatment for stage III colon cancer
C Twelves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2005)
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
CC Chen et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
S Morita et al.
DISEASES OF THE COLON & RECTUM (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
